Literature DB >> 2987786

Sudden hearing loss following infectious mononucleosis: possible effect of altered immunoregulation.

L L Williams, H W Lowery, R Glaser.   

Abstract

Sudden, permanent hearing loss developed in three young patients. In an attempt to determine a viral etiology, their humoral and cell-mediated responses to a panel of seven viruses linked to deafness and altered immunity were measured. Although a specific viral cause was not determined, a mild Epstein-Barr virus infection was documented for each patient. It had preceded their hearing loss onset by 1 to 4 months. Evidence of altered cell-mediated responses to Epstein-Barr virus antigens was found in each patient. It is proposed that, in certain susceptible individuals, a temporary cellular immunosuppression, which accompanies normal recovery from Epstein-Barr virus infection, may provide an opportunity for a viral invasion of, or a latent viral reactivation in, the inner ear. This invasion or reactivation leads to deafness.

Entities:  

Mesh:

Year:  1985        PMID: 2987786

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Acute sensorineural hearing loss immediately following a local anaesthetic dental procedure.

Authors:  T S Tan; M Shoeb; S Winter; M C Frampton
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-01       Impact factor: 2.503

Review 2.  Evaluation of the child with deafness or delayed speech.

Authors:  J Coplan
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

3.  Serum fatty acid proportions are altered during the year following acute Epstein-Barr virus infection.

Authors:  L L Williams; D M Doody; L A Horrocks
Journal:  Lipids       Date:  1988-10       Impact factor: 1.880

4.  Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation.

Authors:  Jeffrey E Gold; Ramazan A Okyay; Warren E Licht; David J Hurley
Journal:  Pathogens       Date:  2021-06-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.